Clinical Characteristics and Microbiology of Community-Acquired Pneumonia
1 other identifier
observational
2,000
1 country
1
Brief Summary
Community-Acquired Pneumonia has become common. Additionally, the mortality is high. But the epidemiology of pathogen is various in different areas, which is crucial for the key treatment. In addition, the risk factors of patients who died in 3 or 7 days in china is not clear, comparing with patients who died in 14 or 28 days or who survived.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2017
CompletedFirst Posted
Study publicly available on registry
April 4, 2017
CompletedStudy Start
First participant enrolled
April 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2019
CompletedApril 5, 2017
April 1, 2017
2 years
March 22, 2017
April 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the epidemiology of pathogen of community-acquired pneumonia in the three hospitals
screen out the pathogen of community-acquired pneumonia
confirmed as community-acquired pneumonia （2 weeks）
Secondary Outcomes (1)
risk factors of patients who died in 3 or 7 days
in one week（3 days or 7days）
Study Arms (3)
Beijing Haidian Hospital
Chinese PLA General Hospital
Beijing Tsinghua Chang gung Hospital
Interventions
Cohort Study； pathogen； clinical features
Eligibility Criteria
patients with commnuity acquired pneumonia
You may qualify if:
- Confirmed community acquired pneumonia
- Age≥18 ys
You may not qualify if:
- HIV infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beijing Haidian Hospitallead
- Beijing Tsinghua Chang Gung Hospitalcollaborator
- Chinese PLA General Hospitalcollaborator
Study Sites (1)
Beijing Haidian Hospital
Beijing, Beijing Municipality, 100000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
March 22, 2017
First Posted
April 4, 2017
Study Start
April 11, 2017
Primary Completion
April 1, 2019
Study Completion
May 1, 2019
Last Updated
April 5, 2017
Record last verified: 2017-04